16/07/2024
Journal: Journal of Cancer Genetics and Biomarkers
Title: Dynamic MicroRNA-Expression In Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
Key Findings: This groundbreaking study highlights that specific patterns of circulating miRNAs in melanoma patients' plasma can indicate cancer progression, PD-L1 status, and overall survival. Notably, nine miRNAs were identified to distinguish different stages of melanoma, with low levels of miR-150-5p linked to poorer overall survival, providing potential biomarkers to predict ICI treatment effectiveness.
Call to Action: Discover more about these promising biomarkers and their implications for melanoma treatment.
Read the full article: https://openaccesspub.org/jcgb/article/2093
Stay informed with the latest advancements in cancer research!